Pyxis Oncology Inc
PYXS
Get informed when a big investor buys or sells
+ FollowMarket Cap$203.37M
Close$
$0.36
89.2% downside
Current Fair Value
89.2% downsideOvervalued by 89.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $203.37 Million |
|---|---|
| Enterprise Value | $202.35 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.28 |
| Beta | 1.34 |
| Outstanding Shares | 63,991,609 |
Return
| Return on Equity | -775.59% |
|---|---|
| Return on Assets | -161.55% |
| Return on Invested Capital | -336.04% |
Valuation & Multiples
| P/E Ratio | -2.28 |
|---|---|
| PEG | -5.98 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 18.33 |
| Enterprise Value to EBIT | -2.19 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 1.56 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 19, 2026
EPS Estimate
$-0.35
Average shareholder expectationRevenue Estimate
$21,875
Average shareholder expectationNext Earnings Call
Expected Date
November 2, 2026
EPS Estimate
$-0.27
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0361▲ 3.61% |
|---|---|
| Total Calls | 523,790▲ 288.28% |
| Total Puts | 18,900▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 53.38%▲ 9.95% |
|---|---|
| Total Invested | $101.14M▲ 149.56% |
| Investors Holding | 83▲ 2.00% |
ESG Score
No data